A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation - Related Studies

A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation

This study has been terminated.

Study NCT00474409. Last updated on September 9, 2008. Information provided by Eisai Medical Research Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Vertigo

2	Additional conditions recognized in this trial
		Cerebral Infarction
		Infarction
		Stroke

3	More general conditions related to this trial
		Brain Diseases
		Brain Infarction
		Brain Ischemia
		Cardiovascular Diseases
		Central Nervous System Diseases
		Cerebrovascular Disorders
		Ear Diseases
		Ischemia
		Labyrinth Diseases
		Necrosis
		Nervous System Diseases
		Neurologic Manifestations
		Otorhinolaryngologic Diseases
		Pathologic Processes
		Signs and Symptoms
		Vascular Diseases
		Vestibular Diseases

4	Interventions listed in this trial
		Merislon

5	Additional drug interventions recognized in this trial
		Betahistine

6	More general drug interventions related to this trial
		Cardiovascular Agents
		Histamine Agents
		Histamine Agonists
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses
		Vasodilator Agents

7	Sponsors listed in this trial
		Eisai China Inc.